CELL THERAPEUTICS NEW (CTIC)

Overview Price 1.10 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $1.10 Daily Range $0.00 - $0.00 52-Week Range $0.95 - $3.33 Volume 0 Cell Therapeutic developing, acquiring and commercializing novel treatments for cancer. Our goal is to build a leading, vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new, less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review, which would expedite the FDA's review of our application. Other Resources for CTIC Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: US Panel to Review CTIC's Pixantrone January 4, 2012 Zacks Blog: Zacks #1 Rank Additions for Friday November 11, 2011 Zacks Blog: CTIC Loss Widens, Resubmits NDA October 27, 2011 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Cell Therapeutics, Bank of New York-Mellon, Safeway, SUPERVALU and The Kroger October 13, 2011 Zacks Blog: CTIC Upped to Outperform October 12, 2011 Cell Therapeutic developing, acquiring and commercializing novel treatments for cancer. Our goal is to build a leading, vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates. The company's research and in-licensing activities are concentrated on identifying new, less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review, which would expedite the FDA's review of our application.   No brokerage coverage for CTIC   CTIC Ratings: BUY  SELL  HOLD CTIC Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 34 Buy 0 Sell   Top Buy Analysis BUY: CTIC Company: CTIC Points: -133.00 Start Price: $10.56 Start Date: 06/04/2009 4:59 AM mzelcs P&P Score: 0.00 Recs: I gonna hold till it goes around 3000 bucks per share. Comments: 2 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
AndrewGreenBull	97.65	01/13/10	First Pick of 2010: TELK	0
AndrewGreenBull	97.65	12/01/09	DARA--Will It be the No.11?	0
Zacks_Analysts	0.00	01/04/12	US Panel to Review CTIC's Pixantrone - Analyst Blog	0
Zacks_Analysts	0.00	10/27/11	CTIC Loss Widens, Resubmits NDA - Analyst Blog	0
Zacks_Analysts	0.00	10/12/11	CTIC Upped to Outperform - Analyst Blog	0
Zacks_Analysts	0.00	10/07/11	Cell Therapeutics Efforts Validated - Analyst Blog	0
Zacks_Analysts	0.00	08/24/11	Good News for Cell Therapeutics - Analyst Blog	0
Zacks_Analysts	0.00	08/23/11	Evenly Poised Cell Therapeutics - Analyst Blog	0
Zacks_Analysts	0.00	08/19/11	CTIC Initiates Opaxio Trial - Analyst Blog	0
Zacks_Analysts	0.00	06/20/11	CTIC Posts Positive Pixantrone Data - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5  >>

Commentary

BUY: CTIC (CTIC) Start Price: $9.18 Points: -121.78 Created: 08/08/2009 August 24th should see $3.00 per share. Comments: 1 | Comment mackkiller Recs:

BUY: CTIC (CTIC) Start Price: $9.24 Points: -131.15 Created: 06/11/2009 New at this I think it will go up seeing that it is going into the phase III of testing Comments: 0 | Comment kenstein Recs:

BUY: CTIC (CTIC) Start Price: $10.26 Points: -133.21 Created: 06/08/2009 stock was over 1000 but pulled back. They have some great products that are pending approval from FDA. Comments: 0 | Comment kenriou Recs:

BUY: CTIC (CTIC) Start Price: $10.26 Points: -133.21 Created: 06/07/2009 FDA approval soon, Possible buyout soon. Either way this is a big money win for investors. Comments: 0 | Comment 68rs327 Recs:

BUY: CTIC (CTIC) Start Price: $10.56 Points: -133.00 Created: 06/04/2009 I gonna hold till it goes around 3000 bucks per share. Comments: 2 | Comment mzelcs Recs:

BUY: CTIC (CTIC) Start Price: $61.20 Points: -90.28 Created: 01/01/2008 Comments: 0 | Comment RMPInvestment Recs:

BUY: CTIC (CTIC) Start Price: $37.20 Points: -89.12 Created: 01/01/2008 Comments: 0 | Comment abr Recs:

BUY: CTIC (CTIC) Start Price: $46.56 Points: -89.72 Created: 01/01/2008 Comments: 0 | Comment idahok Recs:

BUY: CTIC (CTIC) Start Price: $38.64 Points: -89.23 Created: 01/01/2008 Comments: 0 | Comment TraderTony Recs:

BUY: CTIC (CTIC) Start Price: $41.52 Points: -89.43 Created: 01/01/2008 Comments: 0 | Comment remarzouka Recs:

Pages: [ 1 ]  2   3   4  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
mackkiller		BUY	Week to a Month	08/08/2009	$9.18	$1.10 (-0.60%)	-88.02%	+33.77%	-121.78	view close
kenstein		BUY	Week to a Month	06/11/2009	$9.24	$1.10 (-0.60%)	-88.10%	+43.05%	-131.15	view close
kenriou		BUY	Three to Six Months	06/08/2009	$10.26	$1.10 (-0.60%)	-89.28%	+43.93%	-133.21	view close
68rs327		BUY	Week to a Month	06/07/2009	$10.26	$1.10 (-0.60%)	-89.28%	+43.93%	-133.21	view close
mzelcs		BUY	Three Plus Years	06/04/2009	$10.56	$1.10 (-0.60%)	-89.58%	+43.42%	-133.00	view close
RMPInvestment	40.97	BUY	Six Months to a Year	01/01/2008	$61.20	$1.10 (-0.60%)	-98.20%	-7.92%	-90.28
abr	43.28	BUY	Six Months to a Year	01/01/2008	$37.20	$1.10 (-0.60%)	-97.04%	-7.92%	-89.12
idahok	32.66	BUY	Six Months to a Year	01/01/2008	$46.56	$1.10 (-0.60%)	-97.64%	-7.92%	-89.72
TraderTony	78.35	BUY	Six Months to a Year	01/01/2008	$38.64	$1.10 (-0.60%)	-97.15%	-7.92%	-89.23
remarzouka	57.55	BUY	Six Months to a Year	01/01/2008	$41.52	$1.10 (-0.60%)	-97.35%	-7.92%	-89.43

Pages: [ 1 ]  2   3   4  >>